BURNABY, British Columbia (AP) _ Xenon Pharmaceuticals Inc. (XENE) on Tuesday reported a loss of $7.8 million in its second quarter.
On a per-share basis, the Burnaby, British Columbia-based company said it had a loss of 45 cents.
Xenon Pharmaceuticals shares have more than tripled since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $9.95, more than tripling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XENE at https://www.zacks.com/ap/XENE